Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000908 · ClinicalTrials.gov registry record
A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
A clinical trial of HIV Infections and Pneumonia, Pneumocystis Carinii, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 250
- Enrollment target
- 20
- Study locations
NCT00000908: Completed study of HIV Infections and Pneumonia, Pneumocystis Carinii, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00000908 is a study of HIV Infections and Pneumonia, Pneumocystis Carinii that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 250 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000908, a study of HIV Infections and Pneumonia, Pneumocystis Carinii, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to see how often Pneumocystis carinii pneumonia (PCP) occurs in HIV-positive patients who have stopped taking medications that help prevent PCP. The risk of developing PCP may be decreased when an HIV-positive patient's CD4 cell counts (cells of the immune system which fight infection) are more than 200 cells/mm3. This study looks at whether it is acceptable to stop PCP prevention treatment in these patients.
Conditions Studied
Study Locations (20)
California
- Kaiser Foundation Hosp - Harbor City
- Kaiser Permanente LAMC - Los Angeles
- Univ of Southern California / LA County USC Med Ctr - Los Angeles
- Willow Clinic - Menlo Park
- Univ of California / San Diego Treatment Ctr - San Diego
- San Francisco AIDS Clinic / San Francisco Gen Hosp - San Francisco
- San Francisco Gen Hosp - San Francisco
- Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium - San Jose
- Marin County Specialty Clinic - San Rafael
- San Mateo AIDS Program / Stanford Univ - Stanford
- Stanford Univ Med Ctr - Stanford
Hawaii
- Queens Med Ctr - Honolulu
- Univ of Hawaii / Leahi Hosp - Honolulu
Illinois
- Northwestern Univ Med School - Chicago
- Cook County Hosp - Chicago
Alabama
- Univ of Alabama at Birmingham - Birmingham
Colorado
- Univ of Colorado Health Sciences Ctr - Denver
District of Columbia
- Howard Univ - Washington D.C.
Florida
- Univ of Miami School of Medicine - Miami
Georgia
- Emory Univ - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
What the finished NCT00000908 record still lists
NCT00000908 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00000908 names 20 study sites across 8 states, led by California, Hawaii, Illinois.
Frequently Asked Questions
What is clinical trial NCT00000908 about?
NCT00000908 is a clinical study titled "A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts". The purpose of this study is to see how often Pneumocystis carinii pneumonia (PCP) occurs in HIV-positive patients who have stopped taking medications that help prevent PCP. The risk of developing PCP may be decreased when an HIV-positive patient's CD4 cell counts (cells of the immune system which ...
What is the current status of trial NCT00000908?
This trial is currently completed. The enrollment target is 250 participants.
What conditions does trial NCT00000908 study?
This clinical trial studies the following conditions: HIV Infections, Pneumonia, Pneumocystis Carinii.
Who is sponsoring clinical trial NCT00000908?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000908 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00000908's enrollment target sits among peer trials
250 139th of 542 higher than 396 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy